Do You Have Liver Disease? #15135

Location: Minneapolis

Stay: 7 Nights/8 Days Plus 1 Follow-up Phone Call

Gender: Male/Female

Ages: 18-75

Compensation: Up to $2053

Smokers Allowed: No

Study Overview:

The purpose of this study is to look at the impact of liver disease on a study medication called alpelisib, to help doctors determine the proper dosing recommendations when prescribing to a patient with liver disease. We will also examine how the body processes the study medication in someone with liver disease, as compared to someone with normal liver function. Finally, we will evaluate the tolerability and safety of a single dose of the stud drug in all volunteers.

Enroll In This Study